(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of KMO mRNA] CTD PMID:31150632 1,1-dichloroethene decreases expression ISO RGD:734253 6480464 vinylidene chloride results in decreased expression of KMO mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:734253 6480464 1, 2-Dimethylhydrazine results in increased expression of KMO mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of KMO mRNA CTD PMID:25380136 , PMID:30723492 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KMO mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KMO mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737300 6480464 Tetrachlorodibenzodioxin results in decreased expression of KMO mRNA CTD PMID:19692669 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KMO mRNA, Tetrachlorodibenzodioxin results in decreased expression of KMO protein CTD PMID:16054898 more ... 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of KMO mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of KMO mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of KMO protein CTD PMID:34915118 3-hydroxykynurenine multiple interactions EXP 6480464 [KMO protein results in increased hydroxylation of Kynurenine] which results in increased chemical synthesis of 3-hydroxykynurenine CTD PMID:32243540 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737300 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KMO mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of KMO mRNA CTD PMID:25380136 5-methoxytryptamine increases expression EXP 6480464 5-Methoxytryptamine results in increased expression of KMO mRNA CTD PMID:32243540 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of KMO mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:734253 6480464 Aflatoxin B1 results in decreased expression of KMO mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:737300 6480464 Aflatoxin B1 results in decreased methylation of KMO gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:737300 6480464 Aflatoxin B1 results in decreased expression of KMO mRNA CTD PMID:22100608 all-trans-retinoic acid increases expression ISO RGD:737300 6480464 Tretinoin results in increased expression of KMO mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KMO mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:737300 6480464 Antirheumatic Agents results in decreased expression of KMO mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:737300 6480464 Benzo(a)pyrene results in decreased expression of KMO mRNA CTD PMID:32234424 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of KMO mRNA CTD PMID:29945229 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KMO mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A decreases methylation ISO RGD:737300 6480464 bisphenol A results in decreased methylation of KMO gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:737300 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KMO mRNA CTD PMID:28628672 bosentan affects expression ISO RGD:737300 6480464 Bosentan affects the expression of KMO mRNA CTD PMID:29761207 buta-1,3-diene decreases expression ISO RGD:734253 6480464 1, 3-butadiene results in decreased expression of KMO mRNA CTD PMID:29038090 calcitriol decreases expression ISO RGD:737300 6480464 Calcitriol results in decreased expression of KMO mRNA CTD PMID:16002434 carbon nanotube affects expression ISO RGD:734253 6480464 Nanotubes, Carbon analog affects the expression of KMO mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:734253 6480464 Nanotubes, Carbon results in decreased expression of KMO mRNA CTD PMID:25554681 chlorpyrifos increases expression ISO RGD:734253 6480464 Chlorpyrifos results in increased expression of KMO mRNA CTD PMID:32715474 copper atom decreases expression EXP 6480464 Copper results in decreased expression of KMO mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of KMO mRNA CTD PMID:22465980 crocidolite asbestos increases expression ISO RGD:737300 6480464 Asbestos, Crocidolite results in increased expression of KMO mRNA CTD PMID:25351596 cyclosporin A decreases expression ISO RGD:734253 6480464 Cyclosporine results in decreased expression of KMO mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:737300 6480464 Cyclosporine results in decreased expression of KMO mRNA CTD PMID:27989131 cytarabine increases response to substance ISO RGD:737300 6480464 KMO results in increased susceptibility to Cytarabine CTD PMID:21755009 dexamethasone multiple interactions ISO RGD:737300 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KMO mRNA CTD PMID:28628672 dimethoate decreases activity EXP 6480464 Dimethoate results in decreased activity of KMO protein CTD PMID:2119399 dimethylarsinic acid multiple interactions ISO RGD:734253 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KMO mRNA CTD PMID:34876320 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of KMO mRNA CTD PMID:29391264 fipronil increases expression EXP 6480464 fipronil results in increased expression of KMO mRNA CTD PMID:23962444 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of KMO mRNA CTD PMID:24793618 GW 4064 increases expression ISO RGD:734253 6480464 GW 4064 results in increased expression of KMO mRNA CTD PMID:26655953 indometacin multiple interactions ISO RGD:737300 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KMO mRNA CTD PMID:28628672 kynurenic acid multiple interactions EXP 6480464 [Ro 61-8048 results in decreased activity of KMO protein] which results in increased abundance of Kynurenic Acid CTD PMID:30151725 kynurenine multiple interactions EXP 6480464 [KMO protein results in increased hydroxylation of Kynurenine] which results in increased chemical synthesis of 3-hydroxykynurenine CTD PMID:32243540 Lasiocarpine decreases expression ISO RGD:737300 6480464 lasiocarpine results in decreased expression of KMO mRNA CTD PMID:32234424 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of KMO mRNA CTD PMID:35283115 methylarsonic acid multiple interactions ISO RGD:734253 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KMO mRNA CTD PMID:34876320 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:734253 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of KMO mRNA CTD PMID:22401849 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of KMO mRNA CTD PMID:21515302 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of KMO mRNA CTD PMID:19638242 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of KMO mRNA CTD PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:737300 6480464 N-Nitrosopyrrolidine results in decreased expression of KMO mRNA CTD PMID:32234424 nickel atom decreases expression ISO RGD:737300 6480464 Nickel results in decreased expression of KMO mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:737300 6480464 Nickel results in increased expression of KMO mRNA CTD PMID:25583101 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of KMO mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of KMO mRNA CTD PMID:33484710 nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of KMO protein CTD PMID:28659861 O-methyleugenol decreases expression ISO RGD:737300 6480464 methyleugenol results in decreased expression of KMO mRNA CTD PMID:32234424 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of KMO mRNA CTD PMID:23665939 ozone multiple interactions ISO RGD:734253 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of KMO mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:734253 6480464 Acetaminophen affects the expression of KMO mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:737300 6480464 Acetaminophen results in decreased expression of KMO mRNA CTD PMID:21420995 perfluorohexanesulfonic acid increases expression ISO RGD:737300 6480464 perfluorohexanesulfonic acid results in increased expression of KMO mRNA CTD PMID:25812627 perfluorononanoic acid increases expression ISO RGD:737300 6480464 perfluoro-n-nonanoic acid results in increased expression of KMO mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RGD:737300 6480464 perfluoro-n-nonanoic acid results in decreased expression of KMO mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of KMO mRNA, perfluorooctanoic acid results in decreased expression of KMO protein CTD PMID:19162173 , PMID:34958885 phenobarbital multiple interactions ISO RGD:734253 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of KMO mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:734253 6480464 Phenobarbital results in decreased expression of KMO mRNA CTD PMID:19482888 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of KMO mRNA CTD PMID:33945839 pirinixic acid decreases expression ISO RGD:734253 6480464 pirinixic acid results in decreased expression of KMO mRNA CTD PMID:18445702 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of KMO mRNA CTD PMID:19162173 propiconazole decreases expression ISO RGD:734253 6480464 propiconazole results in decreased expression of KMO mRNA CTD PMID:19363144 Ro 61-8048 multiple interactions EXP 6480464 [Ro 61-8048 results in decreased activity of KMO protein] which results in increased abundance of Kynurenic Acid CTD PMID:30151725 Ro 61-8048 decreases activity EXP 6480464 Ro 61-8048 results in decreased activity of KMO protein CTD PMID:30151725 silicon dioxide increases expression ISO RGD:737300 6480464 Silicon Dioxide results in increased expression of KMO mRNA CTD PMID:25351596 sodium arsenate multiple interactions ISO RGD:734253 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KMO mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:737300 6480464 sodium arsenite results in decreased expression of KMO mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:734253 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KMO mRNA CTD PMID:34876320 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of KMO mRNA CTD PMID:25993096 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of KMO mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KMO mRNA CTD PMID:32741896 tetrachloromethane decreases expression ISO RGD:734253 6480464 Carbon Tetrachloride results in decreased expression of KMO mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of KMO mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of KMO mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of KMO mRNA CTD PMID:34492290 valproic acid decreases expression ISO RGD:737300 6480464 Valproic Acid results in decreased expression of KMO mRNA CTD PMID:29154799 valproic acid decreases methylation ISO RGD:737300 6480464 Valproic Acid results in decreased methylation of KMO gene CTD PMID:29154799 vancomycin increases expression ISO RGD:734253 6480464 Vancomycin results in increased expression of KMO mRNA CTD PMID:18930951